Zobrazeno 1 - 10
of 50
pro vyhledávání: '"S. N. Tereschenko"'
Autor:
N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 322-330 (2024)
Aim. To analyze the frequency, indications, and outcomes of using glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) in Russia based on data from a multicenter registry.Material and methods. This work is part of the R
Externí odkaz:
https://doaj.org/article/7b92a445311148e391030de5fc745b45
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 12-18 (2023)
Aim. To evaluate the efficacy of catheter ablation (CA) of atrial fibrillation (AF) in patients with left ventricular systolic dysfunction and the effect of the procedure on the course of chronic heart failure (CHF) compared with the use of antiarrhy
Externí odkaz:
https://doaj.org/article/dd6473ed4ab342248a866809d8770298
Publikováno v:
Терапевтический архив, Vol 92, Iss 4, Pp 37-44 (2020)
Aim. A study of the clinical and instrumental characteristics and quality of treatment of patients with chronic heart failure (CHF) with diabetes mellitus. Materials and methods. The study was conducted by using the CHF register method, which is a
Externí odkaz:
https://doaj.org/article/8a4ba8030c72455198ce1e51a6b1d939
Autor:
S. N. Tereschenko, A. A. Skvortsov, A. Yu. Schedrina, O. Yu. Narusov, K. A. Zykov, A. A. Safiullina, A. V. Sychev, I. V. Zhirov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 22-29 (2017)
Aim. To evaluate diagnostic significance of biomarkers for inflammatory cardiomyopathy (ICM).Material and methods. Totally, 35 patients included with suspected inflammatory cardiomyopathy, chronic heart failure of I-III functional class (FC), decreas
Externí odkaz:
https://doaj.org/article/2f9e0da53f6b4f6dae5736b911bca071
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 1, Iss 1, Pp 19-23 (2015)
The problem of nitrate formulation choice in treatment of patients with ischemic heart disease is reviewed. Importance of development of shortacting nitrates in form of spray, containing nitroglycerin or isosorbid dinitrate, is highlighted. Polycompo
Externí odkaz:
https://doaj.org/article/600655d77d5c4595af7508e46f7c9550
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 703-707 (2015)
Results of experimental and clinical studies devoted to urapidil combining central antihypertensive effect with peripheral vasodilatation are discussed. Scope of urapidil application is described; its good tolerability and safety are highlighted. Ura
Externí odkaz:
https://doaj.org/article/47ae400ceb9b4cbca59ad771de6dfac1
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 46-51 (2015)
Chronic heart failure (CHF) today is a heart condition with the least favourable prognosis. Over the past 10-15 years, in addition to strong rationale supporting the effectiveness of angiotensin-converting enzyme inhibitors (ACEI), results of use wer
Externí odkaz:
https://doaj.org/article/66d27e7b6a5d4616936184c42e05d1db
Autor:
I. V. Zhirov, S. N. Tereschenko
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 32-37 (2015)
In this review data of clinical investifation of serelaxin were briefly outlined. In these trials administration of serelaxin just after admission in the hospitals was acoompanied by middle-term improvement of survival of patients with acute heart fa
Externí odkaz:
https://doaj.org/article/ea7a45f32482434fa5ac80ee8801609e
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 6, Pp 633-639 (2015)
Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy (DCMP) of various etiology.Material and methods. P
Externí odkaz:
https://doaj.org/article/f6668577d9f647c3bd981c86eb42bd1f
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 54-59 (2013)
Till today coronary heart disease (CHD) remains the leading cause of death in the world. Acute forms of CHD, collectively known as acute coronary syndrome (ACS), have a common pathogenesis and similar approaches to diagnosis and treatment. ACS treatm
Externí odkaz:
https://doaj.org/article/bbbf32b63cc74678885cafd2a0d75eba